We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Plug-N-Go is a company that provides electric vehicle charging infrastructure with the aim of sustainably electrifying transport. The company has 24 charge points that are accessible to users via its app. It sources 100% renewable energy from its partners at Octopus Energy. Air pollution is contributing to 40,000 early deaths a year in the UK that Plug-N-Go is striving to change. The global electric vehicle charging stations market will reach USD 27.7 billion by 2027 from an estimated USD 2.5 billion in 2019. The company hopes to become a strong contender in this segment. Plug-N-Go is in discussions over multi-site agreements with the Co-operative Society and Eden district council and has received interest from Associated British Ports. Its goal is to install 3,800 EV charge points for the public in 5 years at sites where drivers are already parking. The company will use the investment to deliver EV charging stations to businesses across the UK.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £176,008
Rabble is a gamified and licensed fitness program that transforms exercise into fun, team-based games. It was first formed by a former international athlete and then financed by investors from the LA Fitness & Liverpool football club. Rabble has quickly risen to 100 authorized sites strengthening many healthy communities over the UK. It is a differentiated concept which is named as Global Fitness Trend (WGSN). It has a proven and scalable model where the market leaders earn revenue of more than $100m. Further, it has developed 100+ instructors across the UK in less than one year. Rabble aims at helping and changing more lives with the finance that it raises. It is planning to grow to more than 300 Rabble sites in the coming year.
days to go: Expired investment: £274,530
Energy bars combining sport nutrition with healthy snacking. Ollybars have designed a natural whole food bar containing 80% whole fruit, seeds and nuts whilst being vegan and gluten-free. The bars are dehydrated to preserve the original nutrition and the packaging is bio-compostable. Their products are sold in more than 300 UK stores and the company nationally distribute and export to the EU. Ollybars are seeking investment to outsource their production due to demand exceeding supply.
days to go: Expired investment: £120,070
Launched in 2017, Algarve Rock is on a mission to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. The global craft beer market is expected to reach nearly $187 billion by 2025. It has carved a niche for itself in only 18 months of its inception. The 3,000 litre Brew House associated fermentation vessels and auto bottling line allow them to produce 36,000 litres per month, readily expandable to 80,000 litres to meet growing demand. Algarve Rock was the winner of the Best Stout - Trujillo Festival 2018, Spain and is the house brewer for prestigious institutions like Quinta do Lago group and Casa do Frango restaurants in London. With the investment, the company will use 40% to open Algarve Rock-themed Brewbars and Brew kiosks, 10% in increasing exports especially to the UK and USA, 10% in strengthening brand identity, 15% in recruitment procedures, and 25% in increasing brewing capacity to cater to new markets.
days to go: Expired investment: £281,607
Offering a more affordable fitness class solution through training small groups and providing unparalleled client care with 1-on-1 personal training sessions. Outrivals has grown rapidly since launching 3 years ago near the famous Old Street Roundabout and are raising funds to open 2 new sites, with plans to have a portfolio of 15 branches over the next 5 years. The company has a high retention rate, with a client life cycle averaging one year.
days to go: Expired investment: £88,450
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
NGX is the world’s first genetically personalised nutrition shake designed to bring nutrition to everyday athletes. The company has ongoing discussions to form partners with U.A.E and U.S to expand. NGX's nutritionist approved formula is a less than average vegan-friendly, environmentally responsible, allergen-free, naturally sourced, and macro trends within the millennial and Z generations. With the proceeds, the company aims to create a range of products from personalised meal plans, and protein bars to enhance its position as the go-to personalised nutrition brand.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £207,860
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph